# Immuno-monitoring of Patients With Metastatic Melanoma (AJCC Stadium IV) Under Chemotherapy

> **NCT02332642** · — · COMPLETED · sponsor: **Universitätsmedizin Mannheim** · enrollment: 12 (actual)

## Conditions studied

- Immuno-monitoring

## Interventions

- **OTHER:** Immuno-monitoring

## Key facts

- **NCT ID:** NCT02332642
- **Lead sponsor:** Universitätsmedizin Mannheim
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2016-12
- **Final completion:** 2016-12-31
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02332642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02332642, "Immuno-monitoring of Patients With Metastatic Melanoma (AJCC Stadium IV) Under Chemotherapy". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02332642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*